Sort
8,912 grants matching “sars cov 2”
Collaborative Research on Influenza, Coronavirus Disease 2019 (COVID-19), and Other Respiratory Pathogens in South Africa
$1,100,000Cheryl Cohen · National Health Laboratory Service · U01 · FY2021 · IP
CEIRR: SARS-CoV-2 Research Activities
$1,097,104Walter Orenstein · Emory University · N01 · FY2022 · AI
Addressing COVID-19 Testing Disparities in Vulnerable Populations Using a Community JITAI (Just in Time Adaptive Intervention) Approach: RADxUP Phase III
$1,096,924Maria Eulalia Fernandez · University Of Texas Hlth Sci Ctr Houston · U01 · FY2023 · TR
Virus Ecology Unit - COVID-19 response
$1,096,841Vincent Munster · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
You and Me Healthy: Testing Protocol
$1,096,719Christoph Hornik · Duke University · U01 · FY2023 · MD
Motivational enhancement to augment contingency management for SARS-CoV-2 testing and vaccination utilization among syringe exchange clients
$1,095,176Anne Marie Mauricio · University Of Oregon · U01 · FY2022 · DA
Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation studies to Evaluate the Safety and Efficacy of SPI-1005 in Moderate and Severe COVID-19 Patients
$1,092,161Jonathan Kil · Sound Pharmaceuticals, Inc. · U01 · FY2022 · TR
Project 1: Panbetacoronavirus vaccines
$1,092,131Barton F Haynes · Duke University · P01 · FY2023 · AI
RI-Center for Clinical and Translational Science
$1,091,210Sharon Irene Smith Rounds · Brown University · U54 · FY2021 · GM
Task B08: Development and Use of a Non-Human Primate Model of SARS-CoV-2 Infection
$1,090,940Karen Thompson · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2020 · AI
Enabling risk-based testing through characterization of environmentally induced immune dysregulation and susceptibility to the SARS-CoV2 virus and COVID-19
$1,090,900Florence Burleson · · N01 · FY2023 · ES
THE SEARCH FOR COVID-19 PREVENTION AND CURE: ADDRESSING THE CRITICAL ROLE OF INNATE/ADAPTIVE IMMUNITY BY INTEGRATING NOVEL INFORMATICS, TRANSLATIONAL TECHNOLOGIES, AND ONGOING CLINICAL TRIAL RESEARCH
$1,088,735Dan M Cooper · University Of California-Irvine · UL1 · FY2020 · TR
Antisense Oligonucleotide (ASO) Development for Rare and Neglected Diseases
$1,088,000Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
Mammalian iron-sulfur cluster biogenesis
$1,086,753Tracey A. Rouault · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
ALZHEIMERS RESEARCH PROJECT: Developing Extraceullar Vesicle biomarkers for clinical and preclinical AD/ADRD
$1,086,297Dimitrios Kapogiannis · National Institute On Aging · ZIA · FY2025 · AG
RBD recombinant protein-based SARS vaccine for biodefense
$1,085,321Peter J Hotez · Baylor College Of Medicine · R01 · FY2013 · AI
India International Center for Excellence in Research
$1,082,746Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Determining factors of transmission and evolution of SARS-CoV-2 in populations at risk
$1,081,195Elodie Ghedin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Development of Brain MRI Contrast Agents
$1,080,628Alan Koretsky · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
Use of Bacteriophages to Prevent, Diagnose, and Treat Diseases
$1,079,030Sankar Adhya · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Addressing COVID-19 Testing Disparities in Vulnerable Populations Using a Community JITAI (Just in Time Adaptive Intervention) Approach: RADxUP Phase III
$1,078,911Maria Eulalia Fernandez · University Of Texas Hlth Sci Ctr Houston · U01 · FY2023 · TR
Administrative Core
$1,078,659Clifford J Rosen · Mainehealth · U54 · FY2025 · GM
CoVPN 3001 A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine LC3
$1,077,287Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
Lakota Center for Health Research
$1,076,264Jeffrey A Henderson · Black Hills Ctr/American Indian Health · S06 · FY2022 · GM
Puerto Rico Community Action Research and Engagement (PR-CARE) to Eliminate Disparities in Diagnostic of COVID-19 among Rural Underserved and Vulnerable Populations.
$1,070,547Marizaida Sanchez · University Of Puerto Rico Med Sciences · U01 · FY2022 · MD